167 research outputs found

    Computations for Coxeter arrangements and Solomon's descent algebra III: Groups of rank seven and eight

    Full text link
    In this paper we extend the computations in parts I and II of this series of papers and complete the proof of a conjecture of Lehrer and Solomon expressing the character of a finite Coxeter group W acting on the pth graded component of its Orlik-Solomon algebra as a sum of characters induced from linear characters of centralizers of elements of W for groups of rank seven and eight. For classical Coxeter groups, these characters are given using a formula that is expected to hold in all ranks.Comment: Minor changes; final versio

    Computations for Coxeter arrangements and Solomon's descent algebra: Groups of rank three and four

    Full text link
    In recent papers we have refined a conjecture of Lehrer and Solomon expressing the characters of a finite Coxeter group WW afforded by the homogeneous components of its Orlik-Solomon algebra as sums of characters induced from linear characters of centralizers of elements of WW. Our refined conjecture also relates the Orlik-Solomon characters above to the terms of a decomposition of the regular character of WW related to the descent algebra of WW. A consequence of our conjecture is that both the regular character of WW and the character of the Orlik-Solomon algebra have parallel, graded decompositions as sums of characters induced from linear characters of centralizers of elements of WW, one for each conjugacy class of elements of WW. The refined conjecture has been proved for symmetric and dihedral groups. In this paper we develop algorithmic tools to prove the conjecture computationally for a given finite Coxeter group. We use these tools to verify the conjecture for all finite Coxeter groups of rank three and four, thus providing previously unknown decompositions of the regular characters and the Orlik-Solomon characters of these groups.Comment: Final version. 20 pages, 6 tables. To appear in J. Symbolic Compu

    Communications Biophysics

    Get PDF
    Contains reports on five research projects

    Integration of Simultaneous Resting-State EEG, fMRI, and Eye Tracker Methods to Determine and Verify EEG Vigilance Measure

    Full text link
    Resting-state functional magnetic resonance imaging (rsfMRI) has been widely used for studying the (presumably) awake and alert human brain. Although rsfMRI scans are typically collected while individuals are instructed to focus their eyes on a fixation cross, objective and verified experimental measures to quantify degree of alertness (e.g., vigilance) are not readily available. Concurrent electroencephalography and fMRI (EEG-fMRI) measurements are also widely used to study human brain with high spatial/temporal resolution. EEG is the modality extensively used for estimating vigilance during eyes-closed resting state. On the other hand, pupil size measured using an eye-tracker device could provide an indirect index of vigilance. In this study, we investigated whether simultaneous multimodal EEG-fMRI combined with eye-tracker measurements can be used to determine EEG signal feature associated with pupil size changes (e.g., vigilance measure) in healthy human subjects (n=10) during brain rest with eyes open. We found that EEG frontal and occipital beta power (FOBP) correlates with pupil size changes, an indirect index for locus coeruleus activity implicated in vigilance regulation (r=0.306, p<0.001). Moreover, FOBP also correlated with heart rate (r=0.255, p<0.001), as well as several brain regions in the anti-correlated network, including the bilateral insula and inferior parietal lobule. These results support the conclusion that FOBP is an objective measure of vigilance in healthy human subjects

    Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo

    Get PDF
    Interaction of bacteria with the immune system within the intestinal mucosa plays a key role in the pathogenesis of inflammatory bowel disease (IBD). The aim of the current study was to develop a fluorescein-aided confocal laser endomicroscopy (CLE) method to visualise intramucosal enteric bacteria in vivo and to determine the involved mucosal area in the colon and ileum in patients with ulcerative colitis (UC) and Crohn's disease (CD)

    Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002-2009

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>To determine whether chlamydia positivity among heterosexual men (MSW) and chlamydia and gonorrhea positivity among men who have sex with men (MSM), are changing.</p> <p>Methods</p> <p>Computerized records for men attending a large sexual health clinic between 2002 and 2009 were analyzed. Chlamydia and gonorrhea positivity were calculated and logistic regression used to assess changes over time.</p> <p>Results</p> <p>17769 MSW and 8328 MSM tested for chlamydia and 7133 MSM tested for gonorrhea. In MSW, 7.37% (95% CI: 6.99-7.77) were chlamydia positive; the odds of chlamydia positivity increased by 4% per year (OR = 1.04; 95% CI: 1.01-1.07; p = 0.02) after main risk factors were adjusted for. In MSM, 3.70% (95% CI: 3.30-4.14) were urethral chlamydia positive and 5.36% (95% CI: 4.82-5.96) were anal chlamydia positive; positivity could not be shown to have changed over time. In MSM, 3.05% (95% CI: 2.63-3.53) tested anal gonorrhea positive and 1.83% (95% CI: 1.53-2.18) tested pharyngeal gonorrhea positive. Univariate analysis found the odds of anal gonorrhea positivity had decreased (OR = 0.93; 95% CI: 0.87-1.00; p = 0.05), but adjusting for main risk factors resulted in no change. Urethral gonorrhea cases in MSM as a percentage of all MSM tested for gonorrhea also fell (p < 0.001).</p> <p>Conclusions</p> <p>These data suggest that chlamydia prevalence in MSW is rising and chlamydia and gonorrhea prevalence among MSM is stable or declining. High STI testing rates among MSM in Australia may explain differences in STI trends between MSM and MSW.</p

    <em>CYP2D6 </em>genotype and adjuvant tamoxifen:meta-analysis of heterogeneous study populations

    Get PDF

    ARTEFACTS: How do we want to deal with the future of our one and only planet?

    Get PDF
    The European Commission’s Science and Knowledge Service, the Joint Research Centre (JRC), decided to try working hand-in-hand with leading European science centres and museums. Behind this decision was the idea that the JRC could better support EU Institutions in engaging with the European public. The fact that European Union policies are firmly based on scientific evidence is a strong message which the JRC is uniquely able to illustrate. Such a collaboration would not only provide a platform to explain the benefits of EU policies to our daily lives but also provide an opportunity for European citizens to engage by taking a more active part in the EU policy making process for the future. A PILOT PROGRAMME To test the idea, the JRC launched an experimental programme to work with science museums: a perfect partner for three compelling reasons. Firstly, they attract a large and growing number of visitors. Leading science museums in Europe have typically 500 000 visitors per year. Furthermore, they are based in large European cities and attract local visitors as well as tourists from across Europe and beyond. The second reason for working with museums is that they have mastered the art of how to communicate key elements of sophisticated arguments across to the public and making complex topics of public interest readily accessible. That is a high-value added skill and a crucial part of the valorisation of public-funded research, never to be underestimated. Finally museums are, at present, undergoing something of a renaissance. Museums today are vibrant environments offering new techniques and technologies to both inform and entertain, and attract visitors of all demographics.JRC.H.2-Knowledge Management Methodologies, Communities and Disseminatio

    Iron Behaving Badly: Inappropriate Iron Chelation as a Major Contributor to the Aetiology of Vascular and Other Progressive Inflammatory and Degenerative Diseases

    Get PDF
    The production of peroxide and superoxide is an inevitable consequence of aerobic metabolism, and while these particular "reactive oxygen species" (ROSs) can exhibit a number of biological effects, they are not of themselves excessively reactive and thus they are not especially damaging at physiological concentrations. However, their reactions with poorly liganded iron species can lead to the catalytic production of the very reactive and dangerous hydroxyl radical, which is exceptionally damaging, and a major cause of chronic inflammation. We review the considerable and wide-ranging evidence for the involvement of this combination of (su)peroxide and poorly liganded iron in a large number of physiological and indeed pathological processes and inflammatory disorders, especially those involving the progressive degradation of cellular and organismal performance. These diseases share a great many similarities and thus might be considered to have a common cause (i.e. iron-catalysed free radical and especially hydroxyl radical generation). The studies reviewed include those focused on a series of cardiovascular, metabolic and neurological diseases, where iron can be found at the sites of plaques and lesions, as well as studies showing the significance of iron to aging and longevity. The effective chelation of iron by natural or synthetic ligands is thus of major physiological (and potentially therapeutic) importance. As systems properties, we need to recognise that physiological observables have multiple molecular causes, and studying them in isolation leads to inconsistent patterns of apparent causality when it is the simultaneous combination of multiple factors that is responsible. This explains, for instance, the decidedly mixed effects of antioxidants that have been observed, etc...Comment: 159 pages, including 9 Figs and 2184 reference

    Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications

    Get PDF
    This work was supported by a restricted research grant of Bayer AG
    corecore